Hyper-IgM syndrome type 4

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Hyper-IgM syndrome type 4 | |
|---|---|
| File:IgM scheme.svg | |
| Synonyms | CD40 ligand deficiency |
| Pronounce | N/A |
| Specialty | Immunology |
| Symptoms | Recurrent infections, low levels of IgG, IgA, and IgE |
| Complications | N/A |
| Onset | Usually in infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the CD40LG gene |
| Risks | Increased susceptibility to opportunistic infections |
| Diagnosis | Genetic testing, measurement of immunoglobulin levels |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Immunoglobulin replacement therapy, antibiotics for infections |
| Medication | N/A |
| Prognosis | Variable, depending on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Hyper-IgM syndrome type 4 is a rare immunodeficiency disorder characterized by a decreased ability to fight infections. This condition is one of several types of hyper-IgM syndrome, which are all distinguished by low levels of certain types of antibodies in the blood.
Symptoms[edit]
People with Hyper-IgM syndrome type 4 have a reduced ability to produce specific types of antibodies, leading to a higher susceptibility to infections. These infections can be recurrent and can affect various parts of the body, including the respiratory system, gastrointestinal tract, and skin.
Causes[edit]
Hyper-IgM syndrome type 4 is caused by mutations in the activation-induced cytidine deaminase (AID) gene. This gene is involved in the process of class switch recombination, which is essential for the production of different types of antibodies.
Diagnosis[edit]
Diagnosis of Hyper-IgM syndrome type 4 is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and specialized tests such as genetic testing to identify mutations in the AID gene.
Treatment[edit]
Treatment is focused on managing the symptoms and preventing infections. This may include antibiotics, immunoglobulin therapy, and in severe cases, hematopoietic stem cell transplantation.
See also[edit]
- Hyper-IgM_syndrome_type_4
-
IgM scheme
-
Class switch recombination